These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 9309767)

  • 1. Validating targets for antiparasite chemotherapy.
    Wang CC
    Parasitology; 1997; 114 Suppl():S31-44. PubMed ID: 9309767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parasite Cathepsin D-Like Peptidases and Their Relevance as Therapeutic Targets.
    Sojka D; Hartmann D; Bartošová-Sojková P; Dvořák J
    Trends Parasitol; 2016 Sep; 32(9):708-723. PubMed ID: 27344362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The current status of antiparasite chemotherapy.
    Croft SL
    Parasitology; 1997; 114 Suppl():S3-15. PubMed ID: 9309765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropeptide signalling: a repository of targets for novel endectocides?
    Mousley A; Marks NJ; Maule AG
    Trends Parasitol; 2004 Oct; 20(10):482-7. PubMed ID: 15363442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic filtering: an approach to discovering novel antiparasitics.
    McCarter JP
    Trends Parasitol; 2004 Oct; 20(10):462-8. PubMed ID: 15363439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Plasmodium falciparum cGMP-dependent protein kinase (PfPKG): antiparasitic activity of a PKG inhibitor.
    Diaz CA; Allocco J; Powles MA; Yeung L; Donald RG; Anderson JW; Liberator PA
    Mol Biochem Parasitol; 2006 Mar; 146(1):78-88. PubMed ID: 16325279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unified QSAR & network-based computational chemistry approach to antimicrobials. II. Multiple distance and triadic census analysis of antiparasitic drugs complex networks.
    Prado-Prado FJ; Ubeira FM; Borges F; González-Díaz H
    J Comput Chem; 2010 Jan; 31(1):164-73. PubMed ID: 19421992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic Inhibitors as Antiparasitic Drugs: Pharmacological, Biochemical and Molecular Perspectives.
    Mukherjee S; Mukherjee N; Gayen P; Roy P; Babu SP
    Curr Drug Metab; 2016; 17(10):937-970. PubMed ID: 27719626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apicomplexa, trypanosoma and parasitic nematode protein kinases as antiparasitic therapeutic targets.
    Liotta F; Siekierka JJ
    Curr Opin Investig Drugs; 2010 Feb; 11(2):147-56. PubMed ID: 20112164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Parasite enzymes as potential targets for antiparasitic chemotherapy.
    Wang CC
    J Med Chem; 1984 Jan; 27(1):1-9. PubMed ID: 6317859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical and metabolic peculiarities of some parasites availing as targets for therapy.
    Frayha GJ; Gobert JG; Savel J
    J Med Liban; 2001; 49(4):210-27. PubMed ID: 12412970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of parasitic disease using vaccines: an answer to drug resistance?
    Vercruysse J; Schetters TP; Knox DP; Willadsen P; Claerebout E
    Rev Sci Tech; 2007 Apr; 26(1):105-15. PubMed ID: 17633296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational drug design using trypanothione reductase as a target for anti-trypanosomal and anti-leishmanial drug leads.
    Austin SE; Khan MO; Douglas KT
    Drug Des Discov; 1999 Jul; 16(1):5-23. PubMed ID: 10466053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyamine transport in parasites: a potential target for new antiparasitic drug development.
    Reguera RM; Tekwani BL; Balaña-Fouce R
    Comp Biochem Physiol C Toxicol Pharmacol; 2005 Feb; 140(2):151-64. PubMed ID: 15907761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
    Lu H; Tonge PJ
    Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The changing landscape of antiparasitic drug discovery for veterinary medicine.
    Geary TG; Conder GA; Bishop B
    Trends Parasitol; 2004 Oct; 20(10):449-55. PubMed ID: 15363437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondria as a promising antiparasitic target.
    Monzote L; Gille L
    Curr Clin Pharmacol; 2010 Feb; 5(1):55-60. PubMed ID: 20236083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Type I DNA topoisomerase from protozoan pathogens as a potential target for anti-tumoral drugs].
    Reguera RM; Pérez-Pertejo Y; Redondo CM; Díaz-González R; Balaña-Fouce R
    Medicina (B Aires); 2007; 67(6 Pt 2):747-57. PubMed ID: 18422072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirtuins as emerging anti-parasitic targets.
    Zheng W
    Eur J Med Chem; 2013 Jan; 59():132-40. PubMed ID: 23220641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.